Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety of Advantage Anti-Caries Varnish
NCT02645617Phase 1Completed
- Sponsor
- Advantage Dental Services
- Start
- Mar 2016
- Primary completion
- Sep 2016
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of IVIEW-1502 in dental caries, sponsored by Advantage Dental Services. Primary endpoint: Presence of adverse oral soft tissue changes at 48 hours. Started Mar 2016; status: completed.
02
Drugs
IVIEW-1502
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT02645617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645617.